December 31, 2024
European Society of Medicine
"Abstract
The novel modRNA vaccinations against Covid-19 were hailed as an immense progress, but indications for severe side effects were noted. We wanted to know to what extent people report having had diseases during the last two years that are associated with Covid-19 vaccinations, and whether there is a difference between those vaccinated and those without vaccinations...
0 Background
... The large phase-3-trials to test the efficacy and safety were hampered right from the start and compromised quickly, as they were neither large enough to detect serious side-effects, nor long enough to discover putative late side-effects. In addition, they had been unblinded early...
Safety signals have indeed been detected, but, due to the political situation, have rarely been acted upon...
Various problems of these vaccines have been reported since, among them myocarditis in children and adults, but also other problems, including excess mortality. Unfortunately, there were no systematic population-wide prospective monitoring studies set up, which might have helped to gauge the effect of benefits against potential side effects...
3 Discussion
... [W]e found that diseases requiring a visit to the doctor are clearly more frequent in the group that was vaccinated (42%) than in the unvaccinated (30%, p=0.0024). Also, Covid-19 is more frequently reported by the vaccinated group (30.2% versus 22.9%, p=0.0535)... It seems that the specificity of the antibody generation induced by the mod-RNA and vector vaccinations is counterproductive in the long run, either because the immune system eschews new variants or because the immune response is itself skewed...
Another shortcoming is the fact that we cannot make distinctions regarding vaccines. A post-hoc analysis of the Paul-Ehrlich-Institute adverse reaction database has shown that the Comirnaty vaccine (Pfizer) produces a rate of 2.8 severe side-effect per 10,000 vaccinations, Spikevax (Moderna) 2.4 per 10,000, Vaxzevria (Astra-Zeneca) 6.0 per 10,000, Jcovden (Janssen) 4.6 per 10,000, and Nuvaxovid (Novavax) 10.1 severe side-effects per 10,000 vaccinations...
4 Conclusions
... These findings show that the promises made by those aggressively promoting the large vaccination campaign were untrue, as is likely the case too for the theoretical models inferring a significant health benefit from the worldwide vaccination programs."
© 2024 European Society of Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
document
adverse events,breakthrough cases,clinical trials,COVID-19,deaths,vaccines